Community Trust & Investment Co Trimmed Its Honeywell International (HON) Position by $400,620 as Stock Value Rose; As Amgen (AMGN) Stock Declined, Shareholder Smead Capital Management Lowered Its Stake

Amgen Inc. (NASDAQ:AMGN) Logo

Community Trust & Investment Co decreased its stake in Honeywell International Inc (HON) by 2.69% based on its latest 2018Q4 regulatory filing with the SEC. Community Trust & Investment Co sold 3,035 shares as the company’s stock rose 7.07% with the market. The institutional investor held 109,615 shares of the o.e.m. company at the end of 2018Q4, valued at $14.48 million, down from 112,650 at the end of the previous reported quarter. Community Trust & Investment Co who had been investing in Honeywell International Inc for a number of months, seems to be less bullish one the $118.72B market cap company. The stock increased 0.08% or $0.13 during the last trading session, reaching $162.99. About 2.06M shares traded. Honeywell International Inc. (NYSE:HON) has risen 9.62% since April 17, 2018 and is uptrending. It has outperformed by 5.25% the S&P500. Some Historical HON News: 09/05/2018 – HONEYWELL – HOMES BUSINESS ON TRACK TO SPIN LATER THIS YEAR INTO A STANDALONE, PUBLICLY TRADED COMPANY; 18/05/2018 – GS Acquisition Holdings CEO is Former Honeywell CEO David Cote; 27/03/2018 – Global Photonic Sensor Market, 2022 – Key Players are Honeywell International, Samsung Electronics, Toshiba & Mitsubishi Electric Corporation – ResearchAndMarkets.com; 18/05/2018 – Honeywell Sees Unit as Standalone Company by End of 3rd Quarter; 17/05/2018 – Industrial Wireless Sensors: 2018 Global Procurement Market Report – Top Five Suppliers are ABB, Honeywell, Emerson, Siemens, and Texas Instruments – ResearchAndMarkets.com; 18/05/2018 – Honeywell: Gili Appointment Effective June 1; 24/05/2018 – Thailand’s IRPC To Build Large Aromatics Complex With Honeywell Technology; 18/05/2018 – HONEYWELL REPORTS ALESSANDRO GILI AS CFO FOR TRANSPORTATION; 02/05/2018 – CFO Moves: MetLife, Honeywell International, Lloyd’s of London; 31/05/2018 – World’s Longest Undersea Tunnel Stays Cool And Reduces Environmental Impact

Smead Capital Management Inc decreased its stake in Amgen Inc (AMGN) by 4.17% based on its latest 2018Q4 regulatory filing with the SEC. Smead Capital Management Inc sold 29,682 shares as the company’s stock declined 5.78% while stock markets rallied. The institutional investor held 681,975 shares of the biological products (no diagnostic substances) company at the end of 2018Q4, valued at $132.76 million, down from 711,657 at the end of the previous reported quarter. Smead Capital Management Inc who had been investing in Amgen Inc for a number of months, seems to be less bullish one the $112.48 billion market cap company. The stock decreased 2.89% or $5.43 during the last trading session, reaching $182.62. About 3.16M shares traded or 10.02% up from the average. Amgen Inc. (NASDAQ:AMGN) has risen 3.54% since April 17, 2018 and is uptrending. It has underperformed by 0.83% the S&P500. Some Historical AMGN News: 17/05/2018 – BeyondSpring to Present Positive Data From Prospective Phase 2 Trial Comparing Plinabulin to Neulasta for the Prevention of Chemotherapy-lnduced Neutropenia at 2018 ASCO Annual Meeting; 09/03/2018 – $CHRS $AMGN Coherus BioSciences IPR patent trial is NOT instituted against Amgen/Roche ‘522 Enbrel patent claims. Could potentially add delay to CHS-0214 biosimilar launch; 17/04/2018 – Amgen Presents First-Of-Its-Kind Data At AAN Annual Meeting Reinforcing Robust And Consistent Efficacy Of Aimovig™ (erenumab); 27/04/2018 – AMGEN GETS POSITIVE CHMP OPINION TO EXPAND USE OF PROLIA® (DENO; 25/05/2018 – FDA CONFIRMS ORPHAN DRUG STATUS FOR AMGEN’S ROMIPLOSTIM; 01/05/2018 – SANOFI & REGENERON TO LOWER NET PRICE OF PRALUENT; 02/04/2018 – STAT Plus: Amgen’s money-back guarantee for its pricey cholesterol drug may not deliver; 18/04/2018 – Amgen at American Academy of Neurology Meeting Apr 24; 24/04/2018 – FOCUS-Express Scripts targets Amgen, Lilly migraine drugs in pricing shift; 21/05/2018 – FDA Approves Prolia® (Denosumab) For Glucocorticoid-Induced Osteoporosis

More important recent Honeywell International Inc. (NYSE:HON) news were published by: Streetinsider.com which released: “AirMedia (AMCN) Subsidiary Reports Strategic Cooperation with Honeywell (HON) to Distribute Satellite Communications Hardware in China – StreetInsider.com” on March 19, 2019, also Seekingalpha.com published article titled: “Honeywell to boost energy efficiency of Newark – Seeking Alpha”, Seekingalpha.com published: “Honeywell CEO sees no impact from Boeing MAX troubles – Seeking Alpha” on March 20, 2019. More interesting news about Honeywell International Inc. (NYSE:HON) was released by: Seekingalpha.com and their article: “Lockheed Martin unveils long-term contracts with more F-35 suppliers – Seeking Alpha” with publication date: April 17, 2019.

Since November 14, 2018, it had 0 buys, and 5 selling transactions for $7.38 million activity. On Wednesday, November 21 Mikkilineni Krishna sold $4.06 million worth of Honeywell International Inc. (NYSE:HON) or 28,281 shares. $629,808 worth of Honeywell International Inc. (NYSE:HON) shares were sold by Deily Linnet F. On Wednesday, November 21 PARDO JAIME CHICO /FA sold $1.94 million worth of Honeywell International Inc. (NYSE:HON) or 13,400 shares. On Wednesday, November 14 DAVIS D SCOTT sold $590,923 worth of Honeywell International Inc. (NYSE:HON) or 3,963 shares.

Community Trust & Investment Co, which manages about $667.70M US Long portfolio, upped its stake in Community Tr Bancorp Inc (NASDAQ:CTBI) by 39,444 shares to 1.78 million shares, valued at $70.62 million in 2018Q4, according to the filing. It also increased its holding in Walmart Inc (NYSE:WMT) by 19,343 shares in the quarter, for a total of 117,014 shares, and has risen its stake in Dowdupont Inc.

Analysts await Honeywell International Inc. (NYSE:HON) to report earnings on April, 19. They expect $1.83 EPS, down 6.15% or $0.12 from last year’s $1.95 per share. HON’s profit will be $1.33 billion for 22.27 P/E if the $1.83 EPS becomes a reality. After $1.91 actual EPS reported by Honeywell International Inc. for the previous quarter, Wall Street now forecasts -4.19% negative EPS growth.

Investors sentiment decreased to 0.98 in 2018 Q4. Its down 0.08, from 1.06 in 2018Q3. It dived, as 62 investors sold HON shares while 493 reduced holdings. 121 funds opened positions while 425 raised stakes. 530.97 million shares or 9.69% more from 484.04 million shares in 2018Q3 were reported. Tiaa Cref Investment Mgmt has 0.67% invested in Honeywell International Inc. (NYSE:HON) for 6.38 million shares. 2,256 were accumulated by Van Strum Towne Inc. The North Carolina-based Piedmont Inv Advsr has invested 0.28% in Honeywell International Inc. (NYSE:HON). The Pennsylvania-based Brinker Capital has invested 0.15% in Honeywell International Inc. (NYSE:HON). Rhumbline Advisers holds 1.24 million shares. Fort Lp reported 11,682 shares or 0.36% of all its holdings. Shelton Capital has invested 0.24% in Honeywell International Inc. (NYSE:HON). Conning reported 24,191 shares. Moller Fincl owns 0.18% invested in Honeywell International Inc. (NYSE:HON) for 2,051 shares. Grassi Investment Mngmt holds 70,890 shares. Sequoia Advsrs reported 4,208 shares. Moreover, Braun Stacey has 0.83% invested in Honeywell International Inc. (NYSE:HON) for 79,761 shares. 4,840 were reported by Portland Glob Advisors Ltd. Donaldson Cap Mngmt Limited Company holds 1.86% or 138,137 shares in its portfolio. Martingale Asset Mgmt Limited Partnership holds 0.65% in Honeywell International Inc. (NYSE:HON) or 374,228 shares.

Investors sentiment increased to 0.99 in Q4 2018. Its up 0.12, from 0.87 in 2018Q3. It is positive, as 63 investors sold AMGN shares while 498 reduced holdings. 113 funds opened positions while 441 raised stakes. 498.05 million shares or 5.87% more from 470.42 million shares in 2018Q3 were reported. First National Bank & Trust & Tru Of Newtown reported 0.17% stake. Axa stated it has 0.33% of its portfolio in Amgen Inc. (NASDAQ:AMGN). 2,660 are held by Drexel Morgan &. Davidson Advisors holds 1.22% or 54,142 shares in its portfolio. Teachers Retirement Systems Of The State Of Kentucky holds 0.51% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 189,754 shares. Parthenon Ltd Liability Corporation invested in 1,369 shares or 0.07% of the stock. Vigilant Mngmt Llc has 3,369 shares. River Road Asset Mgmt Ltd reported 1.25% of its portfolio in Amgen Inc. (NASDAQ:AMGN). First Financial Corporation In holds 0.09% in Amgen Inc. (NASDAQ:AMGN) or 555 shares. Healthcor Limited Partnership holds 0.3% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 51,510 shares. Endurance Wealth Mngmt reported 30,860 shares or 1.12% of all its holdings. Green Square Ltd Liability Corp holds 40,245 shares. Douglass Winthrop Advsrs Ltd Liability Company holds 284,090 shares or 2.75% of its portfolio. Sumitomo Life Ins Co, a Japan-based fund reported 22,884 shares. Mrj Cap Incorporated invested in 19,365 shares or 2.57% of the stock.

Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on April, 23. They expect $3.49 EPS, up 0.58% or $0.02 from last year’s $3.47 per share. AMGN’s profit will be $2.15 billion for 13.08 P/E if the $3.49 EPS becomes a reality. After $3.42 actual EPS reported by Amgen Inc. for the previous quarter, Wall Street now forecasts 2.05% EPS growth.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Nasdaq.com which released: “Health Care Sector Update for 04/02/2019: ADMA, EVOK, ANGO, JNJ, PFE, ABT, MRK, AMGN – Nasdaq” on April 02, 2019, also Nasdaq.com with their article: “Health Care Sector Update for 04/09/2019: VXRT, ZGNX, NVS, JNJ, PFE, ABT, MRK, AMGN – Nasdaq” published on April 09, 2019, Nasdaq.com published: “Health Care Sector Update for 04/10/2019: PTE, PHAS, GH, JNJ, PFE, ABT, MRK, AMGN – Nasdaq” on April 10, 2019. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Fool.com and their article: “Here’s Why Cytokinetics Stock Jumped Today – Motley Fool” published on March 20, 2019 as well as Benzinga.com‘s news article titled: “Second Time’s The Charm For Amgen (NASDAQ:AMGN) As FDA OKs Bone-Building Osteoporosis Drug – Benzinga” with publication date: April 10, 2019.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.